Award recordCONTRACT

TEVA PHARMACEUTICALS USA, INC.

PIID 36E79722D0021· VA Staff Offices· NAC PHARMACEUTICALS (36E797)· 6505 · DRUGS AND BIOLOGICALS· FY2022· $0 net obligations· UEI NEN9A34LRHJ5· NJ

Description

INCORPORATE POINT OF CONTACT CHANGE

Base award description: 1 LINE ITEM FOR ALBUTEROL HFA INHALER WITH DOSE COUNTER

First action · last action
2022-03-29 · 2026-07-23
Transactions
15
First transaction's obligation
$0
Base + all options value (sum of deltas)
$109,085,460
Extent competed
FULL AND OPEN COMPETITION
Other than full & open authority
—
Set-aside
NO SET ASIDE USED.
Offers received
6
SDVOSB flag on record
No
NAICS
325412 · PHARMACEUTICAL PREPARATION MANUFACTURING

Modification chain · 15 transactions

Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.

$1$0Base award · 2022-03-29 · this action $0 · running total $0Modification P00001 · 2022-12-19 · this action $0 · running total $0Modification P00002 · 2023-03-16 · this action $0 · running total $0Modification P00003 · 2023-07-11 · this action $0 · running total $0Modification P00004 · 2023-12-14 · this action $0 · running total $0Modification P00005 · 2023-12-19 · this action $0 · running total $0Modification P00006 · 2024-04-16 · this action $0 · running total $0Modification P00007 · 2024-06-24 · this action $0 · running total $0Modification P00008 · 2024-12-17 · this action $0 · running total $0Modification P00009 · 2025-01-08 · this action $0 · running total $0Modification P00010 · 2025-06-10 · this action $0 · running total $0Modification P00011 · 2025-12-08 · this action $0 · running total $0Modification P00012 · 2026-01-09 · this action $0 · running total $0Modification P00013 · 2026-06-03 · this action $0 · running total $0Modification P00014 · 2026-07-23 · this action $0 · running total $0
  • Base2022-03-29+$0= $0
  • Mod P000012022-12-19+$0= $0
  • Mod P000022023-03-16+$0= $0
  • Mod P000032023-07-11+$0= $0
  • Mod P000042023-12-14+$0= $0
  • Mod P000052023-12-19+$0= $0
  • Mod P000062024-04-16+$0= $0
  • Mod P000072024-06-24+$0= $0
  • Mod P000082024-12-17+$0= $0
  • Mod P000092025-01-08+$0= $0
  • Mod P000102025-06-10+$0= $0
  • Mod P000112025-12-08+$0= $0
  • Mod P000122026-01-09+$0= $0
  • Mod P000132026-06-03+$0= $0
  • Mod P000142026-07-23+$0= $0
TransactionAction dateThis action (delta)Running totalDescription on this transaction
Base2022-03-29+$0$01 LINE ITEM FOR ALBUTEROL HFA INHALER WITH DOSE COUNTER
Mod P00001· OTHER ADMINISTRATIVE ACTION2022-12-19+$0$02023 FCP UPDATES - NATIONAL CONTRACTS FOR ALBUTEROL HFA INHALER WITH DOSE COUNTER.
Mod P00002· ADD SUBCONTRACTING PLAN2023-03-16+$0$02023 SUBK PLAN - NATIONAL CONTRACTS FOR ALBUTEROL HFA INHALER WITH DOSE COUNTER.
Mod P00003· EXERCISE AN OPTION2023-07-11+$0$0EXCERCISE THE 1ST OPTION FOR ALBUTEROL HFA INHALER WITH DOSE COUNTER WITH NO PRICE CHANGES.
Mod P00004· OTHER ADMINISTRATIVE ACTION2023-12-14+$0$02024 PUBLIC LAW UPDATES
Mod P00005· ADD SUBCONTRACTING PLAN2023-12-19+$0$02024 PUBLIC LAW UPDATES
Mod P00006· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE2024-04-16+$0$0COST RECOVERY FEE CHANGE MOD
Mod P00007· EXERCISE AN OPTION2024-06-24+$0$0THIS MODIFICATION IS ISSUED TO EXERCISE THE 2ND OPTION YEAR FOR ALBUTEROL HFA W DOSE COUNTER UNDER CONTRACT 36…
Mod P00008· OTHER ADMINISTRATIVE ACTION2024-12-17+$0$02025 PUBLIC LAW PRICING UPDATES
Mod P00009· ADD SUBCONTRACTING PLAN2025-01-08+$0$0MODIFICATION IS ISSUED TO INCORPORATE TEVA'S 2025 SUBCONTRACTING PLAN
Mod P00010· EXERCISE AN OPTION2025-06-10+$0$0EXERCISING 3RD OPTION YEAR FOR ALBUTEROL HFA W DOSE COUNTER WITH TEVA PHARMACEUTICALS USA, INC. WITH NO PRICE…
Mod P00011· OTHER ADMINISTRATIVE ACTION2025-12-08+$0$0EXERCISING PUBLIC LAW MOD FOR ALBUTEROL HFA W DOSE COUNTER WITH TEVA PHARMACEUTICALS USA, INC. WITH NO PRICE C…
Mod P00012· ADD SUBCONTRACTING PLAN2026-01-09+$0$0INCORPORATE 2026 SUBK PLAN
Mod P00013· EXERCISE AN OPTION2026-06-03+$0$0EXERCISE 4TH OPTION YEAR WITH NO PRICE CHANGES
Mod P00014· OTHER ADMINISTRATIVE ACTION2026-07-23+$0$0INCORPORATE POINT OF CONTACT CHANGE

Related awards · 11

Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.

Other VA awards to the same recipient (UEI NEN9A34LRHJ5)

AwardOffice · PSC / listingNet obligationsFY
36F79726D0125NAC FEDERAL SUPPLY SCHEDULE (36F797) · 6505 · DRUGS AND BIOLOGICALS$0FY2026
36E79723D0023NAC PHARMACEUTICALS (36E797) · 6505 · DRUGS AND BIOLOGICALS$0FY2023
VA797E17A0007NAC PHARMACEUTICALS (36E797) · 6505 · DRUGS AND BIOLOGICALS$0FY2018
V797D70217NAC FEDERAL SUPPLY SCHEDULE (36F797) · 6505 · DRUGS AND BIOLOGICALS$0FY2017
VA797E17C0034NAC PHARMACEUTICALS (36E797) · 6505 · DRUGS AND BIOLOGICALS$0FY2017
VA797E17C0033NAC PHARMACEUTICALS (36E797) · 6505 · DRUGS AND BIOLOGICALS$0FY2017

Other recipients under 6505 from NAC PHARMACEUTICALS (36E797) (most recent first)

AwardRecipientOfficeNet obligationsFY
36E79726A0025CHIESI USA INCNAC PHARMACEUTICALS (36E797)$0FY2026
36E79726A0024NEUROTECH PHARMACEUTICALS, INCNAC PHARMACEUTICALS (36E797)$0FY2026
36E79726A0023TAKEDA PHARMACEUTICALS AMERICA, INC.NAC PHARMACEUTICALS (36E797)$0FY2026
36E79726D0041GOLDEN STATE MEDICAL SUPPLY, INC.NAC PHARMACEUTICALS (36E797)$0FY2026
36E79726A0022AURINIA PHARMA US INCNAC PHARMACEUTICALS (36E797)$0FY2026

Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_IDV_36E79722D0021_3600 · retrieved 2026-09-26.